To view this email as a web page, click here.

You are subscribed to the FormularyWatch eNews.

FormularyWatch

Share

eNews Subscribe

More Subscriptions

FORMULARY WATCH

DRUG PRICING

TODAY'S HEADLINES

Will the government take action on drug pricing?

There are rumors that President Obama could use his executive authority to regulate drug pricing, and the presidential candidates have made the issue their top priority. But can their proposals be implemented? Read more

New drug is breakthrough therapy for bladder cancer

FDA granted breakthrough therapy designation for this new AstraZeneca drug. Read more

CONTINUING PHARMACY EDUCATION

Part 1: Recognition and referral to enhance recovery: The pharmacist's role in managing opioid use disorder

This month's CE activity is open for pharmacists and pharmacy technicians, "Part 1: Recognition and referral to enhance recovery: The pharmacist's role in managing opioid use disorder." Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

Pharmacy companies underinvest in cancer drugs

Pharmaceutical manufacturers typically underinvest in drugs for long-term cancer care. Here are the reasons why. Details

March 02, 2016

Related Articles

Turing reverses decision on 5,000% price hike

Faster FDA approvals lead to cancer drug boom

Click to contact the editorial team. Click to contact the sales team.

Part of the

ModernMedicine logo

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply.
Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

 

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us